미숙아의 신경발달학적 예후 향상을 위한 임상 연구: Erythropoietin과 영양학적 중재

키워드

참고문헌 (88)

1. Juul SE, "Erythropoietin and neonatal neuroprotection", Clin Perinatol, 42, pp.469~481 (2015)
2. McAdams RM JS, "Cerebral Palsy: prevalence, predictability, and parental counseling", NeoReviews, 12, pp.564~574 (2011)
3. Wood NS, "Neurologic and developmental disability after extremely preterm birth", N Engl J Med, 343, pp.378~384 (2000)
4. Marlow N, "Neurologic and developmental disability at six years of age after extremely preterm birth", N Engl J Med, 352, pp.9~19 (2005)
5. Rajagopalan V, "Local tissue growth patterns underlying normal fetal human brain gyrification quantified in utero", J Neurosci, 31, pp.2878~2887 (2011)
6. Lodygensky GA, "Neuroimaging of cortical development and brain connectivity in human newborns and animal models", J Anat, 217, pp.418~428 (2010)
7. McQuillen PS, "Selective vulnerability in the developing central nervous system", Pediatr Neurol, 30, pp.227~235 (2004)
8. Volpe JJ, "The encephalopathy of prematurity--brain injury and impaired brain development inextricably intertwined", Semin Pediatr Neurol, 16, pp.167~178 (2009)
9. Back SA, "Cerebral white and gray matter injury in newborns:new insights into pathophysiology and management", Clin Perinatol, 41, pp.1~24 (2014)
10. Kidokoro H, "New MR imaging assessment tool to define brain abnormalities in very preterm infants at term", AJNR Am J Neuroradiol, 34, pp.2208~2214 (2013)
11. Juul SE, "Neuroprotective potential of erythropoietin in neonates; design of a randomized trial", Matern Health Neonatol Perinatol, 1, pp.27~ (2015)
12. Bartha AI, "Neonatal encephalopathy: association of cytokines with MR spectroscopy and outcome", Pediatr Res, 56, pp.960~966 (2004)
13. Strunk T, "Infection-induced inflammation and cerebral injury in preterm infants", Lancet Infect Dis, 14, pp.751~762 (2014)
14. Jakuskiene R, "Neonatal outcomes of very preterm infants admitted to a tertiary center in Lithuania between the years 2003 and 2005", Eur J Pediatr, 170, pp.1293~1303 (2011)
15. Nagy Z, "Structural correlates of preterm birth in the adolescent brain", Pediatrics, 124, pp.964~972 (2009)
16. Lubsen J, "Microstructural and functional connectivity in the developing preterm brain", Semin Perinatol, 35, pp.34~43 (2011)
17. Masuda S, "Erythropoietic, neurotrophic, and angiogenic functions of erythropoietin and regulation of erythropoietin production", Int J Hematol, 70, pp.1~6 (1999)
18. Sugawa M, "Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation", Neurosci Res, 44, pp.391~403 (2002)
19. Rangarajan V, "Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection", Pediatr Neurol, 51, pp.481~488 (2014)
20. Villa P, "Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis", J Exp Med, 198, pp.971~975 (2003)
21. Xiong Y, "Effects of posttraumatic carbamylated erythropoietin therapy on reducing lesion volume and hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome in rats following traumatic brain injury", J Neurosurg, 114, pp.549~559 (2011)
22. Juul SE, "Pharmacologic neuroprotective strategies in neonatal brain injury", Clin Perinatol, 41, pp.119~131 (2014)
23. Iwai M, "Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic", ischemic brain injury, 2010, pp.41, 1032~1037
24. Neubauer AP, "Erythropoietin improves neurodevelopmental outcome of extremely preterm infants", Ann Neurol, 67, pp.657~666 (2010)
25. van de Looij Y, "Multi-modal assessment of long-term erythropoietin treatment after neonatal hypoxic-ischemic injury in rat brain", PLoS One, 9, pp.e95643~ (2014)
26. Juul SE, "A phase I", II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety, 2008, pp.122, 383~391
27. Fauchere JC, "An approach to using recombinant erythropoietin for neuroprotection in very preterm infants", Pediatrics, 122, pp.375~382 (2008)
28. Fauchere JC, "Safety of early high-dose recombinant erythropoietin for neuroprotection in very preterm infants", J Pediatr, 167, pp.52~57 (2015)
29. Bierer R, "Erythropoietin concentrations and neurodevelopmental outcome in preterm infants", Pediatrics, 118, pp.635~640 (2006)
30. Song J, "Recombinant human erythropoietin improves neurological outcomes in very preterm infants", Ann Neurol, 80, pp.24~34 (2016)
31. Natalucci G, "Effect of early prophylactic high-dose recombinant human erythropoietin in very preterm infants on neurodevelopmental outcome at 2 years: A randomized clinical trial", JAMA, 315, pp.2079~2085 (2016)
32. Ohls RK, "Preschool assessment of preterm infants treated with darbepoetin and erythropoietin", Pediatrics, 137, pp.e20153859~ (2016)
33. Lowe JR, "Impact of erythropoiesis-stimulating agents on behavioral measures in children born preterm", J Pediatr, 184, pp.75~80 (2017)
34. Leuchter RH, "Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age", JAMA, 312, pp.817~824 (2014)
35. Woodward LJ, "Neonatal MRI to predict neurodevelopmental outcomes in preterm infants", N Engl J Med, 355, pp.685~694 (2006)
36. O'Gorman RL, "Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants", Brain, 138, pp.388~397 (2015)
37. Ruegger CM, "Erythropoietin for the repair of cerebral injury in very preterm infants (EpoRepair)", Neonatology, 108, pp.198~204 (2015)
38. Wachs TD, "Issues in the timing of integrated early interventions: contributions from nutrition, neuroscience, and psychological research", Ann N Y Acad Sci, 1308, pp.89~106 (2014)
39. Cusick SE, "The role of nutrition in brain development:vthe golden opportunity of the 'first 1000 days'", J Pediatr, 175, pp.16~21 (2016)
40. Fox SE, "How the timing and quality of early experiences influence the development of brain architecture", Child Dev, 81, pp.28~40 (2010)
41. Schneider N, "Early nutritional interventions for brain and cognitive development in preterm infants: a review of the literature", Nutrients, 9, pp.187~ (2017)
42. dit Trolli SE, "Early lipid supply and neurological development at one year in very low birth weight (VLBW) preterm infants", Early Hum Dev, 88, pp.S25~S29 (2012)
43. Franz AR, "Intrauterine, early neonatal, and postdischarge growth and neurodevelopmental outcome at 5.4 years in extremely preterm infants after intensive neonatal nutritional support", Pediatrics, 123, pp.101~109 (2009)
44. Isaacs EB, "Early diet and general cognitive outcome at adolescence in children born at or below 30 weeks gestation", J Pediatr, 155, pp.229~234 (2009)
45. Biasini A, "Growth and neurological outcome in ELBW preterms fed with human milk and extra-protein supplementation as routine practice: do we need further evidence?", J Matern Fetal Neonatal Med, 25, pp.S72~S74 (2012)
46. Tan M, "Improving head growth in preterm infants--a randomised controlled trial II: MRI and developmental outcomes in the first year", Arch Dis Child Fetal Neonatal Ed, 93, pp.342~346 (2008)
47. Stephens BE, "First-week protein and energy intakes are associated with 18-month developmental outcomes in extremely low birth weight infants", Pediatrics, 123, pp.1337~1343 (2009)
48. Ohnishi S, "Early and intensive nutritional strategy combining parenteral and enteral feeding promotes neurodevelopment and growth at 18months of corrected age and 3 years of age in extremely low birth weight infants", Early Hum Dev, 100, pp.35~41 (2016)
49. Blanco CL, "Impact of early and high amino acid supplementation on ELBW infants at 2 years", J Pediatr Gastroenterol Nutr, 54, pp.601~607 (2012)
50. Beauport L, "Impact of early nutritional intake on preterm brain: a magnetic resonance imaging study", J Pediatr, 181, pp.29~36 (2017)
51. Strommen K, "Enhanced nutrient supply to very low birth weight infants is associated with improved white matter maturation and head growth", Neonatology, 107, pp.68~75 (2015)
52. Fenton TR, "Higher versus lower protein intake in formula-fed low birth weight infants", Cochrane Database Syst Rev, 4, pp.Cd003959~ (2014)[DOI]
53. Lechner BE, "Neurodevelopmental outcomes of preterm infants fed human milk: a systematic review", Clin Perinatol, 44, pp.69~83 (2017)
54. Belfort MB, "Neurodevelopmental outcomes and nutritional strategies in very low birth weight infants", Semin Fetal Neonatal Med, 22, pp.42~48 (2017)
55. Koo W, "Human milk and neurodevelopment in children with very low birth weight: a systematic review", Nutr J, 13, pp.94~ (2014)
56. Zivkovic AM, "Human milk glycobiome and its impact on the infant gastrointestinal microbiota", Proc Natl Acad Sci U S A, 108, pp.S4653~S4658 (2011)
57. Hintz SR, "Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis", Pediatrics, 115, pp.696~703 (2005)
58. Vohr BR, "Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age", Pediatrics, 118, pp.115~123 (2006)
59. Vohr BR, "Persistent beneficial effects of breast milk ingested in the neonatal intensive care unit on outcomes of extremely low birth weight infants at 30 months of age", Pediatrics, 120, pp.953~959 (2007)
60. Tanaka K, "Does breastfeeding in the neonatal period influence the cognitive function of very-low-birth-weight infants at 5 years of age?", Brain Dev, 31, pp.288~293 (2009)
61. Isaacs EB, "Impact of breast milk on intelligence quotient, brain size, and white matter development", Pediatr Res, 67, pp.357~362 (2010)
62. Deoni SC, "Breastfeeding and early white matter development: a cross-sectional study", Neuroimage, 82, pp.77~86 (2013)
63. Belfort MB, "Breast milk feeding, brain development, and neurocognitive outcomes: a 7-year longitudinal study in infants born at less than 30 weeks' gestation", J Pediatr, 177, pp.133~139 (2016)
64. Clandinin MT, "Intrauterine fatty acid accretion rates in human brain:implications for fatty acid requirements", Early Hum Dev, 4, pp.121~129 (1980)
65. Martin CR, "Fatty acid requirements in preterm infants and their role in health and disease", Clin Perinatol, 41, pp.363~382 (2014)
66. Makrides M, "LCPUFAs as conditionally essential nutrients for very low birth weight and low birth weight infants:metabolic, functional, and clinical outcomes-how much is enough?", Clin Perinatol, 41, pp.451~461 (2014)
67. Larque E, "Placental transfer of fatty acids and fetal implications", Am J Clin Nutr, 94, pp.S1908~S1913 (2011)
68. Haggarty P, "Fatty acid supply to the human fetus", Ann Rev Nutr, 30, pp.237~255 (2010)
69. Lauritzen L, "The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina", Prog Lipid Res, 40, pp.1~94 (2001)
70. Larque E, "Perinatal supply and metabolism of long-chain polyunsaturated fatty acids: importance for the early development of the nervous system", Ann N Y Acad Sci, 967, pp.299~310 (2002)
71. Carnielli VP, "The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids", Pediatr Res, 40, pp.169~174 (1996)
72. Martin CR, "Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities", J Pediatr, 159, pp.743~749 (2011)
73. Lu J, "Polyunsaturated fatty acid supplementation alters proinflammatory gene expression and reduces the incidence of necrotizing enterocolitis in a neonatal rat model", Pediatr Res, 61, pp.427~432 (2007)
74. Pawlik D, "Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study", JPEN J Parenter Enteral Nutr, 38, pp.711~716 (2014)
75. Stoll BJ, "Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection", JAMA, 292, pp.2357~2365 (2004)
76. Adams-Chapman I, "Neurodevelopmental outcome of extremely low birth weight infants with Candida infection", J Pediatr, 163, pp.961~967 (2013)
77. Williams JJ, "N-3 fatty acid rich triglyceride emulsions are neuroprotective after cerebral hypoxic-ischemic injury in neonatal mice", PLoS One, 8, pp.e56233~ (2013)
78. Antonietta Ajmone-Cat M, "Docosahexaenoic acid modulates inflammatory and antineurogenic functions of activated microglial cells", J Neurosci Res, 90, pp.575~587 (2012)
79. Smithers LG, "Higher dose of docosahexaenoic acid in the neonatal period improves visual acuity of preterm infants: results of a randomized controlled trial", Am J Clin Nutr, 88, pp.1049~1056 (2008)
80. Molloy CS, "Longterm effect of high-dose supplementation with DHA on visual function at school age in children born at <33 wk gestational age: results from a follow-up of a randomized controlled trial", Am J Clin Nutr, 103, pp.268~275 (2016)
81. Henriksen C, "Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid", Pediatrics, 121, pp.1137~1145 (2008)
82. Westerberg AC, "Attention among very low birth weight infants following early supplementation with docosahexaenoic and arachidonic acid", Acta Paediatr, 100, pp.47~52 (2011)
83. Makrides M, "Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial", JAMA, 301, pp.175~182 (2009)
84. Smithers LG, "Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a followup study of a randomized controlled trial", Am J Clin Nutr, 91, pp.628~634 (2010)
85. Collins CT, "Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial", BMJ Open, 5, pp.e007314~ (2015)[DOI]
86. Almaas AN, "Long-chain polyunsaturated fatty acids and cognition in VLBW infants at 8 years: an RCT", Pediatrics, 135, pp.972~980 (2015)
87. Almaas AN, "Diffusion tensor imaging and behavior in premature infants at 8 years of age, a randomized controlled trial with long-chain polyunsaturated fatty acids", Early Hum Dev, 95, pp.41~46 (2016)
88. Isaacs EB, "10-year cognition in preterms after random assignment to fatty acid supplementation in infancy", Pediatrics, 128, pp.890~898 (2011)

관련 논문AI추천